• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润调节性 T 细胞、CD8/Treg 比值和癌症干细胞与早期乳腺癌患者的淋巴结转移相关。

Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.

机构信息

Hospital de Gineco Obstetricia No. 3 del Centro Médico Nacional la Raza del Instituto Mexicano del Seguro Social, Ciudad de México, México.

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México.

出版信息

Breast Cancer. 2020 Sep;27(5):837-849. doi: 10.1007/s12282-020-01079-y. Epub 2020 Mar 16.

DOI:10.1007/s12282-020-01079-y
PMID:32180141
Abstract

BACKGROUND

Tumor-infiltrating lymphocytes are an important component of the tumor microenvironment (TME) in breast cancer. They have been linked with tumor pathogenesis in advanced stages. However, little is known about their contribution in early phases. In this study, we analyzed the infiltration of leukocytes and cancer stem cells (CSC) in tumors from patients with early breast cancer.

METHODS

Samples of blood and tumor tissue from 30 patients with breast cancer were collected, and the number of dendritic cells (DC), T cells, and CSC were analyzed by flow cytometry.

RESULTS

Tumor-infiltrating CD4 and CD8 T cells expressed higher levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) compared with peripheral T cells. Regulatory T cells (Treg) were enriched in tumors and overexpressed glucocorticoid-induced TNFR-related protein and CTLA-4. Tumor Treg had a positive correlation with the amount of myeloid DC (mDC) and disease progression. The CD8/Treg ratio was associated with lymph node metastasis and tumor stages. The main subset of DC in early breast tumors was mDC, while plasmacytoid DC were almost absent. CSC were present in most tumors with higher frequencies in patients with lymph node metastasis. CSC were also associated with the amount of tumor-infiltrating Treg.

CONCLUSION

Early breast cancer has an inflammatory milieu characterized by mDC, Treg, and CSC infiltration. The frequencies of Treg, CSC and CD8/Treg ratio were associated with disease progression. The composition of leukocytes and the presence of CSC in early breast tumors should be considered for the development of new therapeutic approaches.

摘要

背景

肿瘤浸润淋巴细胞是乳腺癌肿瘤微环境(TME)的重要组成部分。它们与晚期肿瘤的发病机制有关。然而,对于它们在早期阶段的贡献知之甚少。在这项研究中,我们分析了早期乳腺癌患者肿瘤中白细胞和癌症干细胞(CSC)的浸润情况。

方法

收集了 30 名乳腺癌患者的血液和肿瘤组织样本,并通过流式细胞术分析树突状细胞(DC)、T 细胞和 CSC 的数量。

结果

与外周 T 细胞相比,肿瘤浸润的 CD4 和 CD8 T 细胞表达更高水平的细胞毒性 T 淋巴细胞相关抗原 4(CTLA-4)。调节性 T 细胞(Treg)在肿瘤中富集,并过度表达糖皮质激素诱导的 TNFR 相关蛋白和 CTLA-4。肿瘤 Treg 与髓样 DC(mDC)的数量和疾病进展呈正相关。CD8/Treg 比值与淋巴结转移和肿瘤分期相关。早期乳腺癌的主要 DC 亚群是 mDC,而浆细胞样 DC 几乎不存在。CSC 存在于大多数肿瘤中,在有淋巴结转移的患者中频率更高。CSC 还与肿瘤浸润 Treg 的数量相关。

结论

早期乳腺癌具有以 mDC、Treg 和 CSC 浸润为特征的炎症微环境。Treg、CSC 和 CD8/Treg 比值的频率与疾病进展相关。早期乳腺癌肿瘤中白细胞的组成和 CSC 的存在应考虑用于开发新的治疗方法。

相似文献

1
Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.肿瘤浸润调节性 T 细胞、CD8/Treg 比值和癌症干细胞与早期乳腺癌患者的淋巴结转移相关。
Breast Cancer. 2020 Sep;27(5):837-849. doi: 10.1007/s12282-020-01079-y. Epub 2020 Mar 16.
2
Nodal status in luminal A invasive breast cancer: relationships with cytotoxic CD8 + and regulatory FOXP3 + cells tumor-associated infiltrate and other prognostic factors.管腔 A 型浸润性乳腺癌的淋巴结状态:与细胞毒性 CD8+和调节性 FOXP3+细胞肿瘤相关浸润以及其他预后因素的关系。
Virchows Arch. 2021 Nov;479(5):871-882. doi: 10.1007/s00428-021-03126-1. Epub 2021 Jun 12.
3
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.浸润性淋巴细胞、肿瘤特征与早期乳腺癌患者复发。
Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.
4
Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.调节性 T 淋巴细胞浸润转移性乳腺癌-独立的预后因素,其随着肿瘤进展而变化。
Breast Cancer Res. 2021 Feb 18;23(1):27. doi: 10.1186/s13058-021-01403-0.
5
CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.CD4/CD8+T 细胞、树突状细胞亚群、Foxp3 和 IDO 表达是预测胃癌预后的指标。
Cancer Med. 2019 Dec;8(17):7330-7344. doi: 10.1002/cam4.2596. Epub 2019 Oct 20.
6
Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.早期乳腺癌中肿瘤浸润性CD4 + T淋巴细胞反映淋巴结受累情况。
Clinics (Sao Paulo). 2006 Jun;61(3):203-8. doi: 10.1590/s1807-59322006000300004. Epub 2006 Jun 30.
7
GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes.与肿瘤阴性淋巴结相比,晚期乳腺癌患者肿瘤阳性淋巴结中表达 GITR 的调节性 T 细胞亚群增加。
Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):59-66. doi: 10.1177/039463201202500108.
8
Significance of TIM-3 expression by CD4 and CD8 T lymphocytes in tumor-draining lymph nodes from patients with breast cancer.肿瘤引流淋巴结中 CD4 和 CD8 T 淋巴细胞 TIM-3 表达的意义。
Mol Immunol. 2020 Dec;128:47-54. doi: 10.1016/j.molimm.2020.10.002. Epub 2020 Oct 15.
9
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.转移性肿瘤细胞有利于早期宫颈癌患者肿瘤引流淋巴结中耐受性微环境的形成。
Cancer Immunol Immunother. 2009 Sep;58(9):1363-73. doi: 10.1007/s00262-008-0646-7. Epub 2009 Jan 27.
10
Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.低突变和新抗原负担以及较少的效应性肿瘤浸润淋巴细胞与乳腺癌淋巴结转移相关。
Sci Rep. 2019 Jan 22;9(1):253. doi: 10.1038/s41598-018-36319-x.

引用本文的文献

1
CD44 overexpression as a mediator of drug resistance in oral cancer: a meta-analysis unveiling molecular underpinnings and therapeutic implications.CD44过表达作为口腔癌耐药的介导因素:一项揭示分子基础和治疗意义的荟萃分析
Discov Oncol. 2025 Aug 29;16(1):1650. doi: 10.1007/s12672-025-03436-9.
2
New insights on anti-tumor immunity of CD8 T cells: cancer stem cells, tumor immune microenvironment and immunotherapy.CD8 T细胞抗肿瘤免疫的新见解:癌症干细胞、肿瘤免疫微环境与免疫治疗
J Transl Med. 2025 Mar 17;23(1):341. doi: 10.1186/s12967-025-06291-y.
3
Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy.
树突状细胞内源性 PTPN22 负调控抗肿瘤免疫,并影响抗 PD-L1 疗效。
J Immunother Cancer. 2024 Oct 26;12(10):e009588. doi: 10.1136/jitc-2024-009588.
4
Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression.细胞外囊泡与癌症干细胞:肿瘤进展中的致命组合。
Oncol Rev. 2024 Jul 18;18:1411736. doi: 10.3389/or.2024.1411736. eCollection 2024.
5
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy.乳腺癌肿瘤微环境与精准医学:免疫原性及有利于免疫治疗反应的条件。
J Natl Cancer Cent. 2024 Jan 26;4(1):14-24. doi: 10.1016/j.jncc.2024.01.004. eCollection 2024 Mar.
6
Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment-A Cross-Sectional Study.皮肤基底细胞癌和鳞状细胞癌中的浸润 T 细胞:Th1 优势的全球格局与 Th17 富集——一项横断面研究。
Cells. 2024 Jun 3;13(11):964. doi: 10.3390/cells13110964.
7
CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils.CXCL9过表达预示肝癌对抗PD-1治疗有更好的反应并促进中性粒细胞向N1极化。
J Hepatocell Carcinoma. 2024 May 8;11:787-800. doi: 10.2147/JHC.S450468. eCollection 2024.
8
Unveiling the mechanisms and challenges of cancer drug resistance.揭示癌症药物耐药性的机制和挑战。
Cell Commun Signal. 2024 Feb 12;22(1):109. doi: 10.1186/s12964-023-01302-1.
9
Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors.免疫衰老和炎症衰老对免疫检查点抑制剂疗效的影响。
Cancer Pathog Ther. 2023 Aug 9;2(1):24-30. doi: 10.1016/j.cpt.2023.08.001. eCollection 2024 Jan.
10
Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting.癌症干细胞的肿瘤微环境:癌症干细胞靶向治疗的前景
Genes Dis. 2023 Jul 19;11(3):101043. doi: 10.1016/j.gendis.2023.05.024. eCollection 2024 May.